Johnson & Johnson and partner Legend Biotech are expecting an FDA decision for their first CAR-T product, cilta-cel, in November. To prepare for the upcoming launch of the personalized cell therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback